Pacira Pharmaceuticals reported $39.05M in Pre-Tax Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8.96M 0.04M
Adamas Pharmaceuticals ADMS:US -12573000 5.7M
Amerisourcebergen ABC:US $ 670.09M 86.56M
Antares Pharma ATRS:US $ 4.38M 0.72M
Astellas Pharma 4503:JP Y -18903M 94039M
Bristol Myers Squibb BMY:US $ 4761M 820M
Cara Therapeutics CARA:US $ -23301000 101.96M
Endo International Ordinary Shares ENDP:US $ 204.17M 13.97M
Flexion Therapeutics FLXN:US $ -28556000 8.91M
Horizon Pharma HZNP:US $ 33.14M 326.94M
Johnson & Johnson JNJ:US $ 8291M 2690M
Omeros OMER:US $ -35090000 6.34M
Perrigo Ordinary Shares PRGO:US $ 85.7M 68.9M
Pfizer PFE:US $ 6225M 3560M
Revance Therapeutics RVNC:US $ -71.64M 9.39M
Supernus Pharmaceuticals SUPN:US $ 10.93M 28.76M
Teva Pharmaceutical TEVA:IT 144M 761M
Xoma XOMA:US $ -7.37M 30.06M